SOLUBLE AND ANTIGENIC PHOSPHOINOSITIDE PHOSPHATES

可溶性和抗原性磷酸肌醇磷酸盐

• 批准号: 6180732
• 负责人: GLENN DOWNES PRESTWICH
• 金额: $ 24.73万
• 依托单位: ECHELON BIOSCIENCES, INC.
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-05-01 至 2001-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6180732
• 关键词: antigens; biological signal transduction; chemical synthesis; fluorescent dye /probe; monoclonal antibody; phosphatidate phosphatase; phosphatidylinositols; technology /technique development

DESCRIPTION (Adapted from the application): Phosphoinositide polyphosphates (PtdInsPns, or simply PIPns) biosynthesized by the interplay of phosphatases and kinases, are key signaling molecules in cellular communication. The applicant has synthesized and provided "matched sets" of PIPns derivatives of biological interest to researchers worldwide thereby achieving its first tier strategy. During Phase I, we optimized synthesis and characterization of PIPns with four diacyl moieties: (i) short-chain micelle-forming analogs, (ii) intermediate chain amphipathic (or water-soluble) analogs, (iii) long-chain micelle-forming analogs, and (iv) amino-functionalized chains with reporter groups attached. In Phase II, we propose to prepare reagents for the detection of changes in PIPns in biochemical and cellular studies and for use in drug and target discovery efforts. First, the applicant will expand its product line with the incorporation of two series of acyl-modified fluorescent PIPns, the BODIPY and NBD series, to study lipid-dependent signaling pathways. Second, the applicant will employ acyl-functionalized PIPns to prepare antigenic forms of the PIPns and we will use these to prepare PIPn-specific monoclonal antibodies. Third, the applicant will develop immobilized- aminoglycoside columns for the quantitative analysis and purification of naturally occurring synthetic, and chemically modified PIPns. PROPOSED COMMERCIAL APPLICATION: 1. Sale of reagents themselves for basic research. 2. Sales of antibodies themselves for basic research. 3. Drug discovery and forget discovery for new antagonist and enzyme inhibitors.

描述（改编自应用程序）：磷酸肌肽多磷酸（PtdInsPns，或简称PIPns）由磷酸酶和激酶相互作用生物合成，是细胞通信中的关键信号分子。申请人已经合成并向全世界的研究人员提供了具有生物学意义的“匹配组”PIPns衍生物，从而实现了其第一级战略。在第一阶段，我们优化了具有四个二酰基部分的PIPns的合成和表征：(I)短链胶束形成类似物，（ii）中间链两亲性（或水溶性）类似物，（iii）长链胶束形成类似物，以及（iv）附有报告基团的氨基功能化链。在第二阶段，我们计划制备用于生化和细胞研究中检测PIPns变化的试剂，并用于药物和靶点发现工作。首先，申请人将扩大其产品线，纳入两个酰基修饰的荧光pipn系列（BODIPY和NBD系列），以研究脂质依赖性信号通路。其次，申请人将使用酰基功能化的PIPns来制备PIPns的抗原形式，我们将使用这些来制备pipn特异性单克隆抗体。第三，申请人将开发固定化氨基糖苷色谱柱，用于天然合成和化学修饰的PIPns的定量分析和纯化。商业应用建议：销售用于基础研究的试剂本身。2. 销售抗体本身用于基础研究。3. 新拮抗剂和酶抑制剂的药物发现和遗忘发现。